Korea Q4 Roundup: Overseas Sales, M&A Provide Growth Amid General Weakness

Hanmi Dispute Finally Ends

weak earnings
Majority Of Korean Pharma Report Weak Q4 Earnings
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Business